Indian Journal of Pharmacology Home 

SHORT COMMUNICATION
[View FULLTEXT] [Download PDF]
Year : 2022  |  Volume : 54  |  Issue : 1  |  Page : 46--50

Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease

Kinjal V Abhangi, Jigneshkumar Ishwarlal Patel 
 Department of Pharmacology, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India

Correspondence Address:
Dr. Jigneshkumar Ishwarlal Patel
Department of Pharmacology, B. K. Mody Government Pharmacy College, Polytechnic Campus, Bhavnagar Road, Near Aji Dam, Rajkot - 360 003, Gujarat
India

The present study investigates the antiParkinsonian activity of dipeptidyl peptidase-4 (DPP-IV) inhibitor, linagliptin. The experimental Parkinson's disease (PD) was induced by administration of rotenone at a dose of 1.5 mg/kg at alternate day subcutaneously for 21 days. Standard drug (levodopa-200 mg/kg and carbidopa-50 mg/kg) and treatment drug (linagliptin-5 mg/kg, 10 mg/kg, and 20mg/kg) were administered orally daily 1 h before rotenone administration. In a rat rotenone model, linagliptin improved muscle coordination, motor performance, and corrected akinesia. Pretreatment with linagliptin showed significant higher levels of superoxide dismutase, catalase, and glutathione in brain homogenate of animals. Linagliptin significantly elevated the levels of striatal DA and active glucagon-like peptide 1 in brain homogenate of animals. Furthermore, linagliptin amended alterations induced by rotenone in the thiobarbituric acid reactive substances and inflammatory marker such as tumor necrosis factor-α level. The results of the present study indicate the neuroprotective potential of linagliptin for the management of PD might be due to remarkable improvement in motor functions, antioxidant, anti-inflammatory, anti-apoptotic, and neuroprotective mechanisms.


How to cite this article:
Abhangi KV, Patel JI. Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease.Indian J Pharmacol 2022;54:46-50


How to cite this URL:
Abhangi KV, Patel JI. Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease. Indian J Pharmacol [serial online] 2022 [cited 2023 Jan 29 ];54:46-50
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2022;volume=54;issue=1;spage=46;epage=50;aulast=Abhangi;type=0